158 results
Page 4 of 8
8-K
EX-1.1
oz3if3khj0gacr
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
8-K
yjz7h9 d3dbe
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
424B5
so5 fuaqj16kie8
27 Apr 22
Prospectus supplement for primary offering
6:30am
8-K
EX-3.2
u23nio70t827aru49nqk
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.3
dz6r5sce n5v
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-3.1
2cacuyke tqs
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.1
vzhr 5zy235a
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.2
4psroyp9v6lcq
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-10.1
zo3iwast 5tdhcc3h
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
424B5
dvw0zu2lvliwl k6hz
14 Mar 22
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
xaoumz4
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
3xyu z3xvsg9
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-1.1
3jcf9pd1cww6i5ykh7m
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
424B5
qfljtwfd
10 Jan 22
Prospectus supplement for primary offering
8:00am